Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus
Kate Lawrenson(Texas A&M University – San Antonio), Ji‐Yeob Choi(Seoul National University), Elisa V. Bandera(Rutgers, The State University of New Jersey), Hiltrud Brauch(German Cancer Research Center), Jonathan P. Tyrer(University of Cambridge), Qiuyin Cai(Vanderbilt University Medical Center), Natalia Bogdanova(Medizinische Hochschule Hannover), Karoline Kuchenbaeker(University of Cambridge), Jenny Chang‐Claude(Universität Hamburg), Fiona Bruinsma(Cancer Council Victoria), William J. Blot(Shanghai Cancer Institute), Rikki Cannioto(Roswell Park Comprehensive Cancer Center), Anders Bojesen(Vejle Sygehus), Andrew Berchuck(General Marble (Greece)), Janet M. Lee(University of Southern California), Daniel Barrowdale(University of Cambridge), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Susan J. Ramus(Cancer Institute of New South Wales), Irene L. Andrulis(University of Toronto), Karen McCue(Guy's Hospital), Javier Benı́tez(Spanish National Cancer Research Centre), Joan Brunet(Institut Català d'Ornitologia), Carl Blomqvist(University of Helsinki), Melissa K. Delgado(University of Southern California), Rósa B. Barkardóttir(University of Iceland), Paul M. Brennan(Radboud University Nijmegen), Siddhartha Kar(University of Cambridge), Stig E. Bojesen(University of Copenhagen), Saundra S. Buys(University of Utah), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Bernardo Bonanni(European Institute of Oncology), Jocelyne Chiquette(Centre hospitalier universitaire de Québec), Ian Campbell(Roswell Park Comprehensive Cancer Center), Qiyuan Li(Dana-Farber Cancer Institute), Banu Arun(The University of Texas MD Anderson Cancer Center), Brita Arver(Karolinska University Hospital), Barbara Burwinkel(German Cancer Research Center), Ralf Butzow(University of Helsinki), Monica Barile(European Institute of Oncology), Kristiina Aittomäki(University of Helsinki), A.L. Børresen-Dale(University of Oslo), Matthias W Beckmann(Universitätsklinikum Erlangen), Line Bjorge(Haukeland University Hospital), Manjeet K. Bolla(University of Cambridge), Shaik Ahmad Buhari(National University Health System), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Maria Bisogna(Memorial Sloan Kettering Cancer Center), Trinidad Caldes(Peter MacCallum Cancer Centre), Volker Arndt(German Cancer Research Center)
Cited by 0
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k